Literature DB >> 16369535

Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma.

Stephan Mathas1, Martin Janz, Franziska Hummel, Michael Hummel, Brigitte Wollert-Wulf, Simone Lusatis, Ioannis Anagnostopoulos, Andreas Lietz, Mikael Sigvardsson, Franziska Jundt, Korinna Jöhrens, Kurt Bommert, Harald Stein, Bernd Dörken.   

Abstract

B cell differentiation is controlled by a complex network of lineage-restricted transcription factors. How perturbations to this network alter B cell fate remains poorly understood. Here we show that classical Hodgkin lymphoma tumor cells, which originate from mature B cells, have lost the B cell phenotype as a result of aberrant expression of transcriptional regulators. The B cell-specific transcription factor program was disrupted by overexpression of the helix-loop-helix proteins ABF-1 and Id2. Both factors antagonized the function of the B cell-determining transcription factor E2A. As a result, expression of genes specific to B cells was lost and expression of genes not normally associated with the B lineage was upregulated. These data demonstrate the plasticity of mature human lymphoid cells and offer an explanation for the unique classical Hodgkin lymphoma phenotype.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16369535     DOI: 10.1038/ni1285

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  71 in total

1.  Common clonal origin of an acute B-lymphoblastic leukemia and a Langerhans' cell sarcoma: evidence for hematopoietic plasticity.

Authors:  Richard Ratei; Michael Hummel; Ioannis Anagnostopoulos; Doris Jähne; Renate Arnold; Bernd Dörken; Stephan Mathas; Thomas Benter; Oliver Dudeck; Wolf-Dieter Ludwig; Harald Stein
Journal:  Haematologica       Date:  2010-04-26       Impact factor: 9.941

2.  Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma.

Authors:  Björn Lamprecht; Korden Walter; Stephan Kreher; Raman Kumar; Michael Hummel; Dido Lenze; Karl Köchert; Mohamed Amine Bouhlel; Julia Richter; Eric Soler; Ralph Stadhouders; Korinna Jöhrens; Kathrin D Wurster; David F Callen; Michael F Harte; Maciej Giefing; Rachael Barlow; Harald Stein; Ioannis Anagnostopoulos; Martin Janz; Peter N Cockerill; Reiner Siebert; Bernd Dörken; Constanze Bonifer; Stephan Mathas
Journal:  Nat Med       Date:  2010-05-02       Impact factor: 53.440

3.  Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma.

Authors:  Christoph Renné; Jose Ignacio Martin-Subero; Maren Eickernjäger; Martin-Leo Hansmann; Ralf Küppers; Reiner Siebert; Andreas Bräuninger
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

4.  An auto-regulatory loop for EBV LMP2A involves activation of Notch.

Authors:  Leah J Anderson; Richard Longnecker
Journal:  Virology       Date:  2007-11-05       Impact factor: 3.616

Review 5.  [Receptor tyrosine kinases in Hodgkin lymphoma as possible therapeutic targets].

Authors:  C Renné; M L Hansmann; A Bräuninger
Journal:  Pathologe       Date:  2009-09       Impact factor: 1.011

6.  Id2 intrinsically regulates lymphoid and erythroid development via interaction with different target proteins.

Authors:  Ming Ji; Huajie Li; Hyung Chan Suh; Kimberly D Klarmann; Yoshifumi Yokota; Jonathan R Keller
Journal:  Blood       Date:  2008-06-03       Impact factor: 22.113

7.  Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma.

Authors:  Stephan Mathas; Stephan Kreher; Karen J Meaburn; Korinna Jöhrens; Björn Lamprecht; Chalid Assaf; Wolfram Sterry; Marshall E Kadin; Masanori Daibata; Stefan Joos; Michael Hummel; Harald Stein; Martin Janz; Ioannis Anagnostopoulos; Evelin Schrock; Tom Misteli; Bernd Dörken
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-25       Impact factor: 11.205

8.  Balance between Id and E proteins regulates myeloid-versus-lymphoid lineage decisions.

Authors:  Shawn W Cochrane; Ying Zhao; Robert S Welner; Xiao-Hong Sun
Journal:  Blood       Date:  2008-10-16       Impact factor: 22.113

Review 9.  The biology of Hodgkin's lymphoma.

Authors:  Ralf Küppers
Journal:  Nat Rev Cancer       Date:  2008-12-11       Impact factor: 60.716

10.  MyoD and E-protein heterodimers switch rhabdomyosarcoma cells from an arrested myoblast phase to a differentiated state.

Authors:  Zhihong Yang; Kyle L MacQuarrie; Erwin Analau; Ashlee E Tyler; F Jeffery Dilworth; Yi Cao; Scott J Diede; Stephen J Tapscott
Journal:  Genes Dev       Date:  2009-03-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.